	US 11,883,477 B2
	Triple vaccine for diseases caused by Salmonella typhimurium, Riemerella anatipestifer and Escherichia coli
Yongda Zhao, Qingdao (CN); Lili Guo, Qingdao (CN); and Lihua Ma, Qingdao (CN)
Assigned to Qingdao Bolin Biological Technology Co., Ltd., Qingdao (CN)
Filed by Qingdao Bolin Biological Technology Co., Ltd., Qingdao (CN)
Filed on Nov. 22, 2021, as Appl. No. 17/532,217.
Claims priority of application No. 202011315483.6 (CN), filed on Nov. 21, 2020.
Prior Publication US 2022/0193214 A1, Jun. 23, 2022
Int. Cl. A61K 39/112 (2006.01); A61P 31/04 (2006.01); A61K 39/02 (2006.01); A61K 39/108 (2006.01); A61K 39/00 (2006.01)

CPC A61K 39/0275 (2013.01) [A61K 39/0208 (2013.01); A61K 39/0258 (2013.01); A61P 31/04 (2018.01); A61K 2039/521 (2013.01); A61K 2039/70 (2013.01)]

3 Claims

1. An inactivated triple vaccine for diseases in a duck caused by Salmonella typhimurium, Riemerella anatipestifer and Escherichia coli, comprising antigens and an adjuvant, wherein the antigens are an inactivated Salmonella typhimurium S01 strain with a deposit number of CCTCC No. M2020515, an inactivated Riemerella anatipestifer R01 strain with a deposit number of CCTCC No. M2020516 and an inactivated Escherichia coli E01 strain with a deposit number of CCTCC No. M2020514.